Bladder cancer is when a tumor grows in your bladder, a pouch-like organ that stores your urine. (Photo Credit: SEBASTIAN KAULITZKI/Science Source) The American Cancer Society’s estimates for ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The first targeted treatment for the most common form of bladder cancer has been approved for NHS use. The National Institute of Health and Care Excellence (Nice) has given the go-ahead to ...

Platinum-based neoadjuvant chemotherapy (NAC) is a well-established treatment strategy for muscle-invasive bladder cancer (MIBC) prior to radical cystectomy (RC), offering a proven survival benefit.

Bavencio shows efficacy and safety in advanced urothelial carcinoma, regardless of diabetes status, as per JAVELIN Bladder 100 trial findings ... in the Clinical Research Division at Fred Hutch Cancer ...

Cystoprostatectomy is a type of surgery to treat bladder cancer in men. It involves removing both the bladder (called a cystectomy) and the prostate gland (prostatectomy) in men who have cancer ...

antrg.umcn.nl Conclusion Patients with Lynch syndrome carrying an MSH2 mutation are at increased risk of urinary tract cancer including bladder cancer. In these cases surveillance should be considered ...

The US Food and Drug Administration (FDA) has approved a perioperative durvalumab (Imfinzi, AstraZeneca) regimen for adults with muscle-invasive bladder cancer. Specifically, the indication is for ...

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug Administration (FDA) to treat adults with muscle-invasive bladder cancer ...

Zachary Klaassen and Amanda Myers discuss a US claims analysis examining real-world treatment patterns following BCG induction in non-muscle invasive bladder cancer patients. Sam Chang speaks with ...

EG-70 is currently in phase 1/2 development for the treatment of patients with non–muscle invasive bladder cancer (NMIBC). Chan is the senior medical director at enGene and a urologist at the ...